Corvus Pharmaceuticals's market cap is currently $283.37M. The company's EPS TTM is $-0.926; its P/E ratio is ―; Corvus Pharmaceuticals is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is $-0.12. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -151.00K	$ -367.00K	$ -460.00K	$ -632.00K	$ -743.00K
Operating Income	$ -23.41M	$ -32.56M	$ -38.63M	$ -43.76M	$ -48.85M
EBITDA	$ -26.88M	$ -40.94M	$ -42.78M	$ -5.36M	$ -48.85M
Net Income	$ -27.03M	$ -50.05M	$ -38.20M	$ -4.82M	$ -43.75M
Balance Sheet
Cash & Short-Term Investments	$ 27.15M	$ 42.30M	$ 69.45M	$ 44.26M	$ 77.98M
Total Assets	$ 45.55M	$ 68.24M	$ 109.45M	$ 85.53M	$ 83.65M
Total Debt	$ 1.37M	$ 2.60M	$ 3.65M	$ 2.31M	$ 3.19M
Net Debt	$ -11.25M	$ -10.56M	$ -59.81M	$ -14.14M	$ -1.97M
Total Liabilities	$ 6.87M	$ 12.13M	$ 12.29M	$ 13.38M	$ 12.54M
Stockholders' Equity	$ 38.68M	$ 56.12M	$ 97.16M	$ 72.15M	$ 71.11M
Cash Flow
Free Cash Flow	$ -23.97M	$ -27.29M	$ -36.72M	$ -34.85M	$ -37.35M
Operating Cash Flow	$ -23.93M	$ -27.02M	$ -36.72M	$ -34.78M	$ -37.32M
Investing Cash Flow	$ 15.54M	$ -23.28M	$ 21.56M	$ 44.77M	$ 3.25M
Financing Cash Flow	$ 7.86M	$ 0.00	$ 62.16M	$ 1.31M	$ 24.00K

Currency in USD

Corvus Pharmaceuticals Earnings and Revenue History

Income Statement >

Corvus Pharmaceuticals Debt to Assets

Balance Sheet >

Corvus Pharmaceuticals Cash Flow

Cash Flow >

Corvus Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing